Company / EPS (Basic)
Biogen EPS (Basic) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$8.02
FY2025
5-year range
$8.02 / $31.47
FY2021-FY2025
Trend
-61.7%
vs FY2024
Sector context
#7 of 208
Health Care
What the data says
Among 208 Health Care companies, Biogen is in the top 3% for eps (basic). EPS (Basic) has fluctuated over the past 10 years, ranging from $8.02 in FY2025 to $31.47 in FY2021.
Based on SEC 10-K filings.
8.02 in FY2025 with a 5-year CAGR of -18.0%. Top quartile in the Health Care sector.
Declined from $10.44 to $8.02 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -31.4%
- 5-Year CAGR
- -18.0%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 208This company $8.02 Sector average -$1.02
▼
+889.3% above sector average
Key checks
Key Insights
- In FY2025, eps (basic) decreased 61.7% year-over-year.
- Ranks #7 out of 208 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.02 | -61.7% |
| FY2024 | $20.96 | +100.8% |
| FY2023 | $10.44 | -58.0% |
| FY2022 | $24.86 | -21.0% |
| FY2021 | $31.47 | +45.5% |
| FY2020 | $21.63 | +81.2% |
| FY2019 | $11.94 | -29.6% |
| FY2018 | $16.96 | +10.3% |
| FY2017 | $15.38 | +23.8% |
| FY2016 | $12.42 | +58.0% |
As of FY2025 · SEC 10-K · Updated Mar 3, 2026